Successful treatment of anti-PTX3 positive seronegative rheumatoid arthritis with upadacitinib
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES(2024)
摘要
Seronegative rheumatoid arthritis (SNRA) can be a rapid-progressing and highly disabling disease. Anti-PTX3 autoantibody may be a potential biomarker in SNRA diagnosis. SNRA patients could respond well to upadacitinib.
更多查看译文
关键词
anti-PTX3 positivity,seronegative rheumatoid arthritis,upadacitinib
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要